Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cue Biopharma Inc.

    NASDAQ: CUE · Real-Time Price · USD
    0.80
    -0.02 (-2.30%)
    At close: Aug 19, 2025, 10:17 AM

    Cue Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.29M 5.49M 1.25M 14.94M
    Cost of Revenue
    		 2.35M 38.1M 1.81M -1.78M
    Gross Profit
    		 9.29M -32.61M -560.83K 16.72M
    Operating Income
    		 -41.5M -52.15M -53.22M -43.71M
    Interest Income
    		 1.62M 2.66M 928.24K 45.9K
    Pretax Income
    		 -40.67M -50.73M -53.01M -43.67M
    Net Income
    		 -40.67M -50.73M -52.8M -44.16M
    Selling & General & Admin
    		 14.59M 16.68M 16.17M 17.31M
    Research & Development
    		 36.3M 40.8M 38.58M 41.35M
    Other Expenses
    		 -93K -37.94M -35.57M 1.78M
    Operating Expenses
    		 50.79M 19.54M 19.18M 60.43M
    Interest Expense
    		 796K 1.25M 713.82K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 50.79M 57.64M 54.47M 58.65M
    Income Tax Expense
    		 n/a n/a -214.43K 495K
    Shares Outstanding (Basic)
    		 56.33M 45.75M 35.65M 31.29M
    Shares Outstanding (Diluted)
    		 56.33M 45.75M 35.65M 31.29M
    EPS (Basic)
    		 -0.72 -1.11 -1.49 -1.41
    EPS (Diluted)
    		 -0.72 -1.11 -1.49 -1.41
    EBITDA
    		 -37.53M -46.05M -50.49M -45.44M
    EBIT
    		 -39.88M -49.49M -52.3M -43.67M
    Depreciation & Amortization
    		 2.35M 3.44M 1.81M -1.78M

    Add to Watchlist